Boehringer Ingelheim Biopharmaceuticals GmbH specializes in biopharmaceutical contract manufacturing and acts as a central contact point for internal and external customers under the Boehringer Ingelheim BioXcellence™ brand. The company covers the entire value chain, from process development and the production of biological active ingredients to market launch. Both mammalian and microbial technologies are utilized to manufacture complex biopharmaceutical products. The company coordinates procurement and production across various global sites within the corporate group.
Die Forschung, Entwicklung, Herstellung und Vermarktung von biopharmazeutischen Arzneimitteln und ihren Vorprodukten sowie die Erbringung von damit in Zusammenhang stehenden Dienstleistungen.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Mainz Local Court, HRB 44283 (as of 31 October 2026)
| Name | Type | City |
|---|---|---|
| Mario Riesner | Geschäftsführer(in) | Kelkheim/Eppenhain |
| Karsta Rothmaler | Geschäftsführer(in) | Berlin |
| Max Schrecklinger | Geschäftsführer(in) | Eltville am Rhein |
Source: German Commercial Register (Handelsregister) Mainz Local Court, HRB 44283 (as of 31 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 12.01.2021 | Business Purpose Update | Nach Schreibfehlerberichtigung weiterhin: Die Forschung, Entwicklung, Herstellung und Vermarktung von biopharmazeutischen Arzneimitteln und ihren Vorprodukten sowie die Erbringung von damit in Zusammenhang stehenden Dienstleistungen. |
| 31.10.2012 | Company Name Registered | Boehringer Ingelheim Biopharmaceuticals GmbH |
| 31.10.2012 | Registered Seat | Ingelheim am Rhein |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 31.10.2012 | Share Capital Set | — | 500.000 € |
Source: German Commercial Register (Handelsregister) Mainz Local Court, HRB 44283 (as of 31 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €654,074,000 | -€9,233,000 | €870,918,000 | 71 |
| 2023 | €692,724,000 | €24,016,000 | €949,748,000 | 125 |
| 2022 | €752,498,000 | €6,990,000 | €817,682,000 | 125 |
| 2021 | €636,710,000 | €30,423,000 | €704,745,000 | 98 |
| 2020 | €486,658,000 | -€10,837,000 | €614,407,000 | 91 |
| 2019 | €466,743,000 | €40,827,000 | €538,473,000 | 88 |
| 2018 | €402,948,000 | €24,734,000 | €597,665,000 | 81 |
| 2017 | €386,057,000 | €67,234,000 | €575,036,000 | 30 |
| 2016 | €393,067,000 | €26,411,000 | €303,408,000 | 28 |
| 2015 | €376,002,000 | €18,786,000 | €257,431,000 | 28 |
Sign in to download data
Source: German Commercial Register (Handelsregister) Mainz Local Court, HRB 44283 (as of 31 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €12,892,000 | 2.1% |
| Material Costs | €602,907,000 | 97.9% |
